Theravance Biopharma:若交易在特定情况下终止,公司将向Zymeworks支付3250万美元终止费

美股速递
Jun 29

Theravance Biopharma Inc. 披露,根据其与Zymeworks Inc.达成的协议条款,若交易在特定情况下被终止,公司将需向Zymeworks支付一笔高达3250万美元的终止费用。

此项财务安排明确了交易未能完成时的责任归属,为双方的合作设定了清晰的退出机制。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10